Markets closed

Recent Live News & Earnings

IPO TERMS REVISED
ADARx Pharmaceuticals, Inc.ADRX · Nasdaq
$15–$17 / share$350M raise21,875,000 shares

ADARx sets $15-$17 range for $350 million Nasdaq IPO

ADARx just put a number on its RNAi debut: 21.875 million shares at $15 to $17, or roughly $350 million at the midpoint, with J.P. Morgan and Morgan Stanley leading. That makes it one of the largest biotech listings to set terms this year, and pricing is the next step.

Source: SEC filing

Sponsored

Twelve Tabs, One Thesis

Your Research Resets Every Morning

The quote page in one tab. Filings in another. A chart you rebuilt from scratch, a transcript you never went back and found, a screener whose settings you will redo next week. Nothing you built yesterday is still there.

AlphaSpace replaces all of it with one screen you arrange yourself. Earnings calendar, estimate versus actual, the call transcript, live news, your own charts, every panel wired to whatever ticker you click. Close the browser and it is all still sitting there tomorrow.

See What a Built View Looks Like →

(Sponsor)

ABVXABIVAX Société Anonyme
Reports Mon Sep 21After close4:05 PM ETConfirmed

A $9.2 billion market cap resting almost entirely on one ulcerative colitis asset gets its update after the close at 4:05 PM ET. Cash runway and any regulatory milestone commentary are what move this one beyond the quarterly numbers.

    CLOSING BELL
    Asia
    • 🇭🇰 Hang Seng+0.92%
    • 🇨🇳 SSE Composite+0.82%

    Greater China exposure just got a cleaner bid than US investors saw overnight, with Hong Kong and the mainland moving together for once as the Hang Seng closed up 0.92%.

    MARKET OPEN
    Europe
    • 🇬🇧 FTSE 100-0.17%
    • 🇩🇪 DAX+0.61%
    • 🇫🇷 CAC 40+0.58%

    UK-heavy portfolios are carrying a rate risk their continental peers avoid, with the Bank of England leaning toward a hike as inflation runs above 4%. London is lagging at the open, down 0.17% against gains in Frankfurt and Paris.